Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Head and Neck Cancer

NCT00971867 is registered in ClinicalTrials.gov with Bristol-Myers Squibb as lead sponsor.

NCT NCT00971867
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00971867 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Head and Neck Cancer
Lead sponsor
Bristol-Myers Squibb
Phase
Phase 2
Overall status
Completed
Start date
August 4, 2006
Completion date
November 26, 2008
Enrollment
11 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer